Embryonic Stem Cell Research Oversight
NYU School of Medicine’s embryonic stem cell research oversight (ESCRO) committee is responsible for approving and registering all research protocols involving the use of human embryonic stem cells or human pluripotent stem cells.
Our committee consists of a diverse group of faculty and staff with expertise in human embryonic stem cell research. We evaluate research protocols to ensure their compliance with institutional, state, and federal regulations—including those of the National Institutes of Health, National Academy of Sciences, Empire State Stem Cell Board, International Society for Stem Cell Research, and NYU School of Medicine.
If you intend to submit a research protocol involving human embryonic stem cells or human pluripotent stem cells, we provide information about how to apply, as well as clarification of the committee review process. Prior to beginning research, all investigators and study personnel must complete required training and agree to our policy.
Faculty, staff, and visiting researchers with a Kerberos ID can log onto our ESCRO intranet community to see a list of committee members, as well as institutional policies and procedures.